Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells

Toxicological Sciences

Volumn 79, Issue 1, 2004, Pages 56-63

  Sens, Donald A ^a   Park, Seongmi ^a   Gurel, Volkan ^a   Sens, Mary Ann ^a   Garrett, Scott H ^a   Somji, Seema ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Arsenic; Arsenite; Bladder cancer; Cadmium; Cell culture; UROtsa

Indexed keywords

AGAR; ARSENIC TRIOXIDE; CADMIUM; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER EPITHELIUM; CELL CULTURE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; POLLUTANT; TRANSITIONAL CELL CARCINOMA; TUMOR XENOGRAFT; UROTHELIUM;

AGAR; ANIMALS; ARSENICALS; CADMIUM COMPOUNDS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TIME FACTORS; URINARY BLADDER; UROTHELIUM;

MUS MUSCULUS;

EID: 2442657871     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh086     Document Type: Article

References (27)

1. Achanzar, W. E., Brambila, E. M., Diwan, B. A., Webber, M. M., and Waalkes, M, P. (2002). Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 94, 1888-1891.
2. Achanzar, W. E., Diwan, B. A., Liu, J., Quader, S. T., Webber, M. M., and Waalkes, M. P. (2001). Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res. 61, 455-458.
3. ATSDR. (1997). Top 20 Hazardous Substances: ATSDR/EPA Priority List for 1997. Agency for Toxic Substances and Disease Registry, Atlanta, GA.
4. Basu, A., Mahata, J., Gupta, S., and Giri, A. K. (2001). Genetic toxicology of a paradoxical human carcinogen, arsenic: A review. Mutat. Res. 488, 171-194.
5. Chiou, H. Y., Hsueh, Y., Liaw, K. F., Horng, S. F., Chiang, M. H., Pu, Y. S., Lin, J. S., Huang, C. H., and Chen, C. J. (1995). Incidence of internal cancers and ingested inorganic arsenic: A 7-year follow-up study in Taiwan. Cancer Res. 55, 1296-1300.
6. Denizot, F., and Lang, R. (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89, 271-277.
7. Elinder, C.-F. (1985). Normal values for cadmium in human tissues, blood, and urine in different countries. In Cadmium and Health: A Toxicological and Epidemiological Appraisal (L. Friberg, C.-F. Elinder, T. Kjellstrom, and G.F. Nordberg, Eds.), pp. 81-102. CRC Press, Boca Raton, FL.
8. Goering, P. L., Waalkes, M. P., and Klaassen, C. D. (1995). Toxicology of cadmium. In Toxicology of Metals: Biochemical Aspects (R.A. Goyer and M.G. Cherian, Eds.), pp. 189-214. Springer-Verlag, Berlin.
9. Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicolli, H., and Smith, A. H. (1996). Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7, 117-124.
10. International Agency for Research on Cancer. (1980). Some Metals and metallic compounds. In IARC Monographs on the Evalulation of the Carcinogenic Risk of Chemicals to Man. Vol. 23. IARC, Lyon, France.
11. International Agency for Research on Cancer. (1993). Beryllium, cadmium, mercury, and exposure in the glass manufacturing industry. In International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 58. IARC, Lyon, France.
12. Johansson, S. I., and Cohen, S. M. (1997). Epidemiology and etiology of bladder cancer. Semin. Surg. Oncol. 13, 291-298.
13. Kitchin, K. T. (2001). Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
14. Petzoldt, J. L., Leigh, I. M., Duffy, P. G., and Masters, J. R. W. (1994). Culture and characterization of human urothelium in vivo and in vitro. Urol. Res. 22, 67-74.
15. Petzoldt, J. L., Leigh, I. M., Duffy, P. C., Sexton, C., and Masters, J. R. W. (1995). Immortalization of human urothelial cells. Urol. Res. 23, 377-380.
16. Rehn, L. (1895). Blasengeschwulte bei fuchsin-arbeitern. Arch. Klin. Chir. 50, 588.
17. Rossi, M. R., Masters, J. R. W., Park, S., Todd, J. H., Garrett, S. H., Sens, M. A., Somji, S., Nath, J., and Sens, D. A. (2001). The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ. Health Perspect. 109, 801-808.
18. Rossi, M. R., Somji, S., Garrett, S. H., Nath, J., and Sens, D. A. (2002). Expression of hsp27, hsp60, hsc70, and hsp 70 stress response genes in cultured human urothelial cells (UROtsa) exposed to lethal and sublethal concentrations of sodium arsenite. Environ. Health Perspect. 110, 1225-1232.
19. Rossman, T. G., Uddin, A. N., Burns, F. J., and Bosland, M. C. (2001). Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176, 64-71.
20. San, R. H. C., Laspia, M. F., Soiefer, A. I., Maslansky, C. J., Rice, J. M., and Williams, G. M. (1979). A survey of growth in soft agar and cell surface properties as markers for transformation in adult rat liver epithelial-like cell cultures. Cancer Res. 39, 1026-1034.
21. 2. J. Toxicol. Environ. Health A. 66, 2031-2046.
22. Siemiatycki, J., Dewar, R., Nadon, L., and Gerin, M. (1994). Occupational risk factors for bladder cancer: Results from a case-control study in Montreal, Quebec, Canada. Am. J. Epidemiol. 140, 1061-1080.
23. Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998). Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147, 660-669.
24. Steinmaus, C., Moore, L., Hopenhayn-Rich, C., Biggs, M. L., and Smith, A. H. (2000). Arsenic in drinking water and bladder cancer. Cancer Invest. 18, 174-182.
25. Tsuda, T., Babazono, A., Yamamoto, E., Kurumatini, N., Mino, Y., Ogawa, T., Kishi, Y., and Aoyama, H. (1995). Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am. J. Epidemiol. 141, 198-209.
26. Waalkes, M. P., Rehm, S., Coogan, T. P., and Ward, J. M. (1997). Role of cadmium in the etiology of cancer of the prostate. In Endocrine Toxicology, 2nd ed. (J.A. Thomas and H.D Colby, Eds.), pp. 227-243. Taylor and Francis, Washington, DC.
27. Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., and Fukushima, S. (1999). Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20, 1873-1876.